Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...
The Inactivated Vaccines Market was valued at US$ 40.6 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 ...
Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its ...
Request Your Sample Now! The Sorbitol Market is expected to achieve substantial growth, reaching USD 3,380.3 million by 2034 ...
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging ...